|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03486262 |
|
Date of registration:
|
27/03/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization
K-FPI |
|
Scientific title:
|
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization |
|
Date of first enrolment:
|
February 1, 2018 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Unknown status |
|
URL:
|
https://clinicaltrials.gov/show/NCT03486262 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Auréie CAZES, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Assistance Publique - Hôpitaux de Paris |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Lung carcinoma
- Idiopathic pulmonary fibrosis
Exclusion Criteria:
- No tumor sample available
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Lung Cancer and Idiopathic Pulmonary Fibrosis
|
|
Primary Outcome(s)
|
|
Molecular profile of IPF-associated lung carcinomas
[Time Frame: 1 month / 8 samples]
|
|
Secondary Outcome(s)
|
|
Pathological characterization of lung carcinomas
[Time Frame: 1 month / 8 samples]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|